Kezar Life Sciences
43 hedge funds and large institutions have $28.2M invested in Kezar Life Sciences in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
11% less capital invested
Capital invested by funds: $31.6M → $28.2M (-$3.42M)
27% less funds holding
Funds holding: 59 → 43 (-16)
73% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 22
Holders
43
Holding in Top 10
1
Calls
$84K
Puts
$9K
Top Buyers
| 1 | +$2.39M | |
| 2 | +$591K | |
| 3 | +$398K | |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$327K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$217K |
Top Sellers
| 1 | -$949K | |
| 2 | -$732K | |
| 3 | -$282K | |
| 4 |
Two Sigma Advisers
New York
|
-$270K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$263K |